Skip to main content

DCVC Opportunity Fund II GP, LLC

13F filer · CIK 0001668343
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$17.2MU.S. long equity reported on 13F
Positions20 new · 0 closed
Net flow last quarter-$507KBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20262 positions
RXRXRecursion Pharmaceuticals, Inc.$14.5M84.30%0.74%Not reportedQ4 2021
IONQIonQ, Inc.$2.7M15.70%0.01%-15.8%Q4 2025
Q1 2026Reported May 15, 20262 positions
RXRXRecursion Pharmaceuticals, Inc.$12.1M87.48%0.74%Not reportedQ4 2021
IONQIonQ, Inc.$1.74M12.52%0.02%+532.6%Q4 2025
Q4 2025Reported Feb 17, 20262 positions
RXRXRecursion Pharmaceuticals, Inc.$16.2M97.42%0.75%Not reportedQ4 2021
IONQIonQ, Inc.$427K2.58%0.00%NewQ4 2025
Q3 2025Reported Nov 14, 20251 positions
RXRXRecursion Pharmaceuticals, Inc.$19.3M100.00%0.80%Not reportedQ4 2021
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.